Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains.
We asked whether HIV-1 had the capacity to establish a persistent infection of cultured human diploid fibroblasts. Human strains of normal diploid embryo lung fibroblasts were infected with HIV-1 of the HTLV-IIIB and HIV-1P1 strains. Infection was followed over time, to analyze HIV expression. Virus production (intra- and extracellular virus) was evaluated as follows: ability to form syncytia in the C8166 T cell line, production of p24 and other viral antigens (ELISA and indirect immunofluorescence), search for a gag sequence in cell DNA by the polymerase chain reaction followed by hybridization to an HIV-1-specific probe (SK19). Cell-free culture supernatant was used as a virus source to infect de novo fibroblasts and C8166 T cells. Infection of cultured fibroblasts with either the HTLV-IIIB or HIV-1P1 strain led regularly to the establishment of persistently infected cultures. Fibroblast cells were capable of continuous virus production for at least 10 months. The released virus was capable of reinfecting cultured fibroblasts and of producing cytopathic effects in the C8166 T cell line. However, when compared to wild-type strains, the infectious virus derived from fibroblasts showed a prolonged replication cycle and a decreased ability to form syncytia in the T cell line. Therefore, HIV-1 can establish a persistent and productive infection in normal lung fibroblasts. The data are consistent with the hypothesis that in vivo, at least in the lung, fibroblasts may represent a virus reservoir and that infection of these cells may lead to the production of attenuated variants of HIV.
Dolei
A
A
Institute of Microbiology and Virology, University of Sassari, Italy.
Serra
C
C
Arca
M V
MV
Tilocca
F
F
Riva
E
E
Antonelli
G
G
Dianzani
F
F
Toniolo
A
A
D002460:Cell Line; D004622:Embryo, Mammalian; D004797:Enzyme-Linked Immunosorbent Assay; D005347:Fibroblasts / Q000821:virology; D015726:Giant Cells; D015488:HIV Antigens / Q000032:analysis / Q000096:biosynthesis; D016655:HIV Core Protein p24 / Q000032:analysis / Q000096:biosynthesis; D015497:HIV-1 / Q000472:pathogenicity* / Q000502:physiology*; D006801:Humans; D008168:Lung; D008561:Membrane Fusion; D016133:Polymerase Chain Reaction; D013601:T-Lymphocytes; D014779:Virus Replication
D015488:HIV Antigens; D016655:HIV Core Protein p24